ZOLADEX(Goserelin) Side Effects

Common adverse reactions include hormonal sequelae, while rare events involve metabolic and vascular complications.

Clinical and Postmarketing Safety Profile

Frequent adverse reactions (>10% incidence) include hot flashes (64%), sexual dysfunction, and urinary symptoms. Tumor flare manifests as transient pain or disease progression. Radiation combination therapy increases gastrointestinal/bladder toxicity (e.g., rectal bleeding, cystitis). Postmarketing reports note osteoporosis, hypercalcemia, pituitary apoplexy (presenting as sudden headache or vision changes), and psychiatric disorders. 

Rare cardiovascular events (angina, stroke) and injection-related hemorrhage underscore the need for monitoring. Laboratory anomalies include reversible liver enzyme elevations and lipid changes. Hypersensitivity and QT prolongation are clinically significant but uncommon. Long-term androgen suppression may necessitate bone density management via bisphosphonates.

ZOLADEX(Goserelin)
ZOLADEX is indicated for Locally Confined Prostate Cancer (Stage B2–C) or advanced prostate carcinoma.
RELATED ARTICLES
Goserelin treatment of breast cancer patients

Goserelin sustained-release injection is suitable for prostate cancer, uterine leiomyoma, and breast cancer....

Wednesday, July 23rd, 2025, 16:41
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved